(Alliance News) - Stocks in London were mixed at the open on Friday ahead of the release of a key gauge of US economic health, the non-farm payrolls report, which many expect to influence the size of the Federal Reserve's next interest rate hike at its next meeting this month. Read More
(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted a marketing authorisation application for momelotinib, its treatment for myelofibrosis, a rare bone marrow cancer. Additionally, it announced positive results from a trial investigating Jemperli. Read More
(Alliance News) - Stocks in London are set to open marginally lower on Friday, ahead of US non-farm payrolls later in the day, a piece of data expected to loom large for the US Federal Reserve at its December meeting. Read More
(Alliance News) - London's FTSE 100 index was outperforming on Tuesday morning as a rising Brent price lifted its heavyweight oil stocks, while other equities were shaken by further Covid measures in China. Read More
(Alliance News) - GSK PLC on Tuesday said it has started the process to withdraw US marketing authorisation for its cancer drug, Blenrep, on the request of the US Food & Drug Administration. Read More
(Alliance News) - Stocks in London were called slightly higher on Tuesday, as a rising Brent oil price supported the FTSE 100 index, despite unease over Covid-related developments in China. Read More
(Alliance News) - Equities in Europe were celebrating a cooler-than-expected US CPI print on Thursday, which gave rise to hopes that peak inflation in the US has passed. Read More
(Alliance News) - Stock prices in London came to a mixed closed on Monday, as the FTSE 100 underperformed its European peers, while the domestically-focused FTSE 250 index saw a stronger day. Read More
(Alliance News) - The FTSE 100 stood out on Monday, but for the wrong reason, as share price falls for some of its largest constituents meant the index London large-caps underperformed versus the mid-cap FTSE 250 and European indices. Read More
(Alliance News) - GSK PLC on Monday said that its blood cancer drug, Blenrep, has failed to meet its primary endpoint of progression-free survival in recent phase three trials. Read More
(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi SA, has received EU approval for prevention of the virus in newborns and infants. Read More
(Alliance News) - GSK PLC on Thursday said it was stopping enrolment for its gepotidacin antibiotic trial early, following a recommendation by the Independent Data Monitoring Committee. Read More
(Alliance News) - Stock prices in London edged into the red at midday on Wednesday, as the market awaited a key US interest rate decision, but welcomed positive business updates from GSK and Next. Read More
(Alliance News) - GSK PLC on Wednesday raised its 2022 guidance and said its respiratory syncytial virus older adult vaccine candidate has been granted priority review by the US Food & Drug Administration. Read More
